Clinical Trial Update: Use of Serial Plasma NGS as a New Efficacy Metric to Guide Immunotherapy Treatment Discontinuation [NA]

View source ↗

Summary

Massachusetts General Hospital describes using serial plasma NGS as a new efficacy metric to guide immunotherapy treatment discontinuation. The study includes p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Non-small Cell Lung Cancer

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Melanoma, Non-small Cell Lung Cancer | NA | Status: ACTIVE_NOT_RECRUITING